Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74, 229–263 (2024).
Chen, S. et al. Estimates and Projections of the Global Economic Cost of 29 Cancers in 204 Countries and Territories From 2020 to 2050. JAMA Oncol. 9, 465–472 (2023).
de Magalhaes, J. P. How ageing processes influence cancer. Nat. Rev. Cancer 13, 357–365 (2013).
Mandelblatt, J. S. et al. Applying a life course biological age framework to improving the care of individuals with adult cancers: review and research recommendations. JAMA Oncol. 7, 1692–1699 (2021).
Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646–674 (2011).
Ferrucci, L. et al. Measuring biological aging in humans: A quest. Aging Cell 19, e13080 (2020).
Hanahan, D. Hallmarks of cancer: new dimensions. Cancer Discov. 12, 31–46 (2022).
Swanton, C. et al. Embracing cancer complexity: Hallmarks of systemic disease. Cell 187, 1589–1616 (2024).
Kroemer, G. et al. From geroscience to precision geromedicine: Understanding and managing aging. Cell 188, 2043–2062 (2025).
Jylhava, J., Pedersen, N. L. & Hagg, S. Biological Age Predictors. EBioMedicine 21, 29–36 (2017).
Bell, C. G. et al. DNA methylation aging clocks: challenges and recommendations. Genome Biol. 20, 249 (2019).
Melzer, D., Pilling, L. C. & Ferrucci, L. The genetics of human ageing. Nat. Rev. Genet 21, 88–101 (2020).
Horvath, S. & Raj, K. DNA methylation-based biomarkers and the epigenetic clock theory of ageing. Nat. Rev. Genet 19, 371–384 (2018).
Bell, C. G. et al. DNA methylation aging clocks: challenges and recommendations. Genome Biol. 20, https://doi.org/10.1186/s13059-019-1824-y (2019).
Han, L. K. M. et al. Accelerating research on biological aging and mental health: Current challenges and future directions. Psychoneuroendocrinology 106, 293–311 (2019).
Horvath, S. DNA methylation age of human tissues and cell types. Genome Biol. 14, R115 (2013).
Hannum, G. et al. Genome-wide methylation profiles reveal quantitative views of human aging rates. Mol. Cell 49, 359–367 (2013).
Horvath, S. et al. Epigenetic clock for skin and blood cells applied to Hutchinson-Gilford Progeria Syndrome and ex vivo studies. Aging 10, 1758–1775 (2018).
Levine, M. E. et al. An epigenetic biomarker of aging for lifespan and healthspan. Aging 10, 573–591 (2018).
Lu, A. T. et al. DNA methylation GrimAge strongly predicts lifespan and healthspan. Aging 11, 303–327 (2019).
Belsky, D. W. et al. Quantification of the pace of biological aging in humans through a blood test, the DunedinPoAm DNA methylation algorithm. Elife 9, https://doi.org/10.7554/eLife.54870 (2020).
Belsky, D. W. et al. DunedinPACE, a DNA methylation biomarker of the pace of aging. Elife 11, https://doi.org/10.7554/eLife.73420 (2022).
Sugden, K. et al. Patterns of Reliability: Assessing the Reproducibility and Integrity of DNA Methylation Measurement. Patterns 1, https://doi.org/10.1016/j.patter.2020.100014 (2020).
Higgins-Chen, A. T. et al. A computational solution for bolstering reliability of epigenetic clocks: implications for clinical trials and longitudinal tracking. Nat. Aging 2, 644 (2022).
Rentscher, K. E. et al. Epigenetic aging in older breast cancer survivors and noncancer controls: preliminary findings from the Thinking and Living with Cancer Study. Cancer 129, 2741–2753 (2023).
Flavahan, W. A., Gaskell, E. & Bernstein, B. E. Epigenetic plasticity and the hallmarks of cancer. Science 357, https://doi.org/10.1126/science.aal2380 (2017).
Verma, M. et al. Epigenetic research in cancer epidemiology: trends, opportunities, and challenges. Cancer Epidemiol. Biomark. Prev. 23, 223–233 (2014).
Ahadi, S. et al. Personal aging markers and ageotypes revealed by deep longitudinal profiling. Nat. Med. 26, 83–90 (2020).
Li, X., Schottker, B., Holleczek, B. & Brenner, H. Associations of DNA methylation algorithms of aging and cancer risk: Results from a prospective cohort study. EBioMedicine 81, 104083 (2022).
Zhang, Y. et al. DNA methylation signatures in peripheral blood strongly predict all-cause mortality. Nat. Commun. 8, 14617 (2017).
Holleczek, B., Schöttker, B. & Brenner, H. Helicobacter pylori infection, chronic atrophic gastritis and risk of stomach and esophagus cancer: Results from the prospective population-based ESTHER cohort study. Int. J. Cancer 146, 2773–2783 (2020).
Schöttker, B., Muhlack, D. C., Hoppe, L. K., Holleczek, B. & Brenner, H. Updated analysis on polypharmacy and mortality from the ESTHER study. Eur. J. Clin. Pharmacol. 74, 981–982 (2018).
Löw, M., Stegmaier, C., Ziegler, H., Rothenbacher, D. & Brenner, H. Epidemiological investigations of the chances of preventing, recognizing early and optimally treating chronic diseases in an elderly population (ESTHER study). Dtsch. Med. Wochenschr. 129, 2643–2647 (2004).
Miller, S. A., Dykes, D. D. & Polesky, H. F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16, 1215 (1988).
Li, X. et al. Comparative validation of three DNA methylation algorithms of ageing and a frailty index in relation to mortality: results from the ESTHER cohort study. EBioMedicine 74, 103686 (2021).
Zhang, Y., Saum, K. U., Schöttker, B., Holleczek, B. & Brenner, H. Methylomic survival predictors, frailty, and mortality. Aging 10, 339–357 (2018).
Houseman, E. A. et al. DNA methylation arrays as surrogate measures of cell mixture distribution. BMC Bioinforma. 13, 86 (2012).
Grambsch, P. M. & Therneau, T. M. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 81, 515–526 (1994).
